Genexine rights offering by third-party allotment, Oct 16, 2026
Genexine · KOSDAQ · 095700 · Oct 16, 2026
· Rights offerings
Genexine filed a rights offering on Oct 16, 2026. The allocation method is third-party allotment.
Key facts
| Allocation method | Third-party allotment |
Comparison
| Revenue 2025 | ₩4.6bn |
| Revenue 2024 | ₩2.9bn |
| Revenue 2023 | ₩4.4bn |
Key metrics
Potential dilution
| CB/BW/EB issued, last 12 months | ₩0 As of Nov 19, 2026 |
| Rights offering new shares, last 12 months | Not available |
| Potential new shares, last 12 months | Not available |
| Potential new shares, % of shares | Not available |
| Conversion price adjustments, last 12 months | 0 As of Nov 19, 2026 |
Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)